Document is current

Article History

Accepted: 22 October 2024

First Online: 9 November 2024

Declarations

:

: REP was supported by a Canadian Institutes of Health Research Doctoral Research Award. The Canadian Network for Learning Healthcare Systems and Cost-effective ‘Omics Innovation (CLEO) is supported by Genome BC/Genome Canada [G05CHS]. The funders were not involved in the writing of the manuscript or the decision to submit it for publication.

: DAR’s institution has received research funding for a project from Roche Canada and DAR has received travel funding from Illumina. REP, MS, SB and SP declare that they have no conflict of interest.

: REP and DAR conceptualized the study. REP acquired data and conducted data analysis, with review and verification by DAR. All authors contributed to review and interpretation of results. REP wrote the initial draft, and all authors conducted critical review and revision of the manuscript.

: Access to data provided by the Data Stewards is subject to approval but can be requested for research projects through the Data Stewards or their designated service providers. The following data sets were used in this study: BC Cancer Registry, Population Data BC Consolidation File (Registration and Premium Billing), Hospital Separations (Discharge Abstracts Database), Medical Services Plan (MSP) Payment Information File, Vital Statistics Deaths File, and PharmaNet. You can find further information regarding these data sets by visiting the PopData project webpage at: . All inferences, opinions, and conclusions drawn in this publication are those of the author(s) and do not reflect the opinions or policies of the Data Steward(s).

: This study was approved by the University of British Columbia-BC Cancer Research Ethics Board, certificate H15-03418.

: Not applicable.

: Not applicable.

: Code is available by request from the corresponding author.